Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nora Eisemann

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Deutsches Arzteblatt International|October 2, 2024
In ReplyNora Eisemann
Deutsches Arzteblatt International|October 3, 2015
Skin Cancer Screening in Germany. Documenting Melanoma Incidence and Mortality From 2008 to 2013Alexander Katalinic, Nora Eisemann, Annika Waldmann
Hematological Oncology|March 12, 2015
Prediction of chronic lymphocytic leukaemia incidence in Germany and of patients ineligible for standard chemotherapyNora Eisemann, Maike Schnoor, Alexander Katalinic
BMC Medical Research Methodology|September 21, 2011
Imputation of missing values of tumour stage in population-based cancer registrationNora Eisemann, Annika Waldmann, Alexander Katalinic
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 25, 2017
[The cartographic depiction of regional variation in morbidity : Data analysis options using the example of the small-scale cancer atlas for Schleswig-Holstein]Ron Pritzkuleit, Nora Eisemann, Alexander Katalinic
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|November 10, 2018
[Skin cancer screening in Germany: review after ten years]Joachim Hübner, Nora Eisemann, Alicia Brunßen, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 10, 2013
Quality of life in partners of patients with localised prostate cancerNora Eisemann, Annika Waldmann, Volker Rohde, et al.
Journal of Medical Screening|November 25, 2017
Observed and expected mortality in the German skin cancer screening pilot project SCREENNora Eisemann, Annika Waldmann, Bernd Holleczek, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 28, 2015
Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010Christiane Rudolph, Maike Schnoor, Nora Eisemann, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 23, 2014
Development of a microsimulation of melanoma mortality for evaluating the effectiveness of population-based skin cancer screeningNora Eisemann, Annika Waldmann, Claus Garbe, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Deutsches Arzteblatt International|October 2, 2024
In ReplyNora Eisemann
Deutsches Arzteblatt International|October 3, 2015
Skin Cancer Screening in Germany. Documenting Melanoma Incidence and Mortality From 2008 to 2013Alexander Katalinic, Nora Eisemann, Annika Waldmann
Hematological Oncology|March 12, 2015
Prediction of chronic lymphocytic leukaemia incidence in Germany and of patients ineligible for standard chemotherapyNora Eisemann, Maike Schnoor, Alexander Katalinic
BMC Medical Research Methodology|September 21, 2011
Imputation of missing values of tumour stage in population-based cancer registrationNora Eisemann, Annika Waldmann, Alexander Katalinic
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 25, 2017
[The cartographic depiction of regional variation in morbidity : Data analysis options using the example of the small-scale cancer atlas for Schleswig-Holstein]Ron Pritzkuleit, Nora Eisemann, Alexander Katalinic
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|November 10, 2018
[Skin cancer screening in Germany: review after ten years]Joachim Hübner, Nora Eisemann, Alicia Brunßen, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 10, 2013
Quality of life in partners of patients with localised prostate cancerNora Eisemann, Annika Waldmann, Volker Rohde, et al.
Journal of Medical Screening|November 25, 2017
Observed and expected mortality in the German skin cancer screening pilot project SCREENNora Eisemann, Annika Waldmann, Bernd Holleczek, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 28, 2015
Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010Christiane Rudolph, Maike Schnoor, Nora Eisemann, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 23, 2014
Development of a microsimulation of melanoma mortality for evaluating the effectiveness of population-based skin cancer screeningNora Eisemann, Annika Waldmann, Claus Garbe, et al.
Pageof 6